“HIGH-DOSE-RATE AND LOW-DOSE-RATE BRACHYTHERAPY AS MONOTHERAPY FOR CLINICALLY LOCALIZED PROSTATE CANCER”. Voprosy Onkologii, vol. 65, no. 3, Mar. 2019, pp. 434-40, https://doi.org/10.37469/0507-3758-2019-65-3-434-440.